awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q36405822-72E21E52-3981-4CE2-A143-DDA829F63BDD
Q36405822-72E21E52-3981-4CE2-A143-DDA829F63BDD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36405822-72E21E52-3981-4CE2-A143-DDA829F63BDD
De novo engineering of a human cystathionine-γ-lyase for systemic (L)-Methionine depletion cancer therapy.
P2860
Q36405822-72E21E52-3981-4CE2-A143-DDA829F63BDD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36405822-72E21E52-3981-4CE2-A143-DDA829F63BDD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5c736cae086f783c44dae619c6c0caee079eec40
P2860
FDA drug approval summary: pegaspargase (oncaspar) for the first-line treatment of children with acute lymphoblastic leukemia (ALL).